NASDAQ · SHCR
Sharecare, Inc.
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
NASDAQ · ISO · USD
Stock price, earnings
Quote as of Mar 20, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
IsoPlexis Corporation’s quoted price sits in the lower half of its reported 52-week range, 80.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow IsoPlexis Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform. This comprehensive system integrates specialized instruments, consumable chips, and advanced software, delivering an end-to-end solution for observing protein activity and function at the individual cellular level. Its instrument lineup includes the IsoLight and IsoSpark systems. For chip consumables, it offers IsoCode chips, designed for multiplexed single-cell functional proteomics, and CodePlex chips, which provide multiplexed analysis for ultra-low volume bulk samples. The IsoSpeak software further enhances the platform, providing robust dimensional data analysis and automating workflows through an intuitive, push-button user interface. This enables rapid, same-day visualization of both single-cell and bulk proteome data. Beyond its core products, IsoPlexis also extends research support and post-warranty services. Established in 2013, the company operates from its base in Branford, Connecticut.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$10.66-1,249.37% vs estimate |
| $4.19M-90.33% vs estimate |
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
$0.81-$0.00 (-0.44%)
Elutia Inc’s quoted price sits in the lower half of its reported 52-week range, 41.73% below the high.
$5.75+$0.02 (+0.35%)
Science 37 Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.63% below the high.
$0.71+$0.02 (+2.45%)
HEXO Corp.’s quoted price sits in the lower half of its reported 52-week range, 81.49% below the high.
$0.55$0.00 (0.0%)
Marinus Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.76% below the high.
$1.00$0.00 (0.0%)
Angion Biomedica Corp.’s quoted price sits in the lower half of its reported 52-week range, 95.1% below the high.
$0.33+$0.00 (+0.22%)
Allakos Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.9% below the high.
$4.30-$0.14 (-3.15%)
AnPac Bio-Medical Science Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 64.14% below the high.
